Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-10,794
Closed -$794K 63
2021
Q1
$794K Sell
10,794
-4,192
-28% -$309K 0.26% 27
2020
Q4
$1.17M Sell
14,986
-103
-0.7% -$7.88K 0.44% 24
2020
Q3
$1.19M Buy
15,089
+103
+0.7% +$8.07K 0.52% 20
2020
Q2
$1.11M Sell
14,986
-210
-1% -$15.8K 0.56% 22
2020
Q1
$1.12M Hold
15,196
0.64% 18
2019
Q4
$1.32M Hold
15,196
0.67% 22
2019
Q3
$1.22M Hold
15,196
0.68% 21
2019
Q2
$1.22M Buy
15,196
+210
+1% +$16.1K 0.71% 22
2019
Q1
$1.19M Sell
14,986
-6,192
-29% -$463K 0.7% 21
2018
Q4
$1.59M Buy
+21,178
New +$1.5M 0.69% 22

Other funds holding MRK

BT Wealth Management's MRK Position: Q2 2021 in Review

BT Wealth Management sold out of Merck (MRK) in Q2 2021, closing a stake of 10,794 shares — an estimated $794K sold.

BT Wealth Management first reported a position in MRK in Q4 2018 and held it in 10 quarters. The position peaked at $1.59M in Q4 2018. 2,673 funds tracked by Wall St. Rank hold MRK as of Q2 2021.

  • BT Wealth Management reported no remaining Merck position as of Q2 2021 after selling out during the quarter.
  • BT Wealth Management sold 10,794 Merck shares in Q2 2021, an estimated $794K.
  • BT Wealth Management first reported a position in Merck in Q4 2018 and held it in 10 quarters.
  • BT Wealth Management's Merck position peaked at $1.59M in Q4 2018.
  • 2,673 funds tracked by Wall St. Rank held Merck as of Q2 2021.

Based on BT Wealth Management's 13F filing for Q2 2021, filed 28 Jul 2021.